SCENT 1. Differences in smellprints between patients with lung cancer and breast cancer.

Smellprints in lung Cancer; the role of ENose in diagnosis and Treatment (SCENT): part 1. Differences in smellprints between patients with lung cancer and breast cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28095

Enrollment

100

Registered

2008-12-29

Start date

2009-01-02

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eNose (electronische neus) smell-print (geurprofiel) lung cancer (longkanker) breast cancer (borstkanker) exhaled breath (uitademingslucht)

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Written informed consent obtained. Lung cancer patients: 1. Adults 18-80 years; 2. Non small cell lung cancer (NSCLC). Lung cancer controls: 1. Adults 18-80 years; 2. Matched for: a. Age: age3 months. c. Sex. Breast cancer patients: 1. Women 18-80 years; 2. Breast cancer. Breast cancer controls: 1. Women 18-80 years; 2. Matched for: a. Age: age3 months.

Exclusion criteria

Exclusion criteria: 1. Other known pulmonary diseases; 2. Other or former malignancy; 3. Pregnancy; 4. Diabetes mellitus (documented in the past); 5. Hypercholesterolaemia (documented in the past); 6. Significant cardiovascular disease; 7. Any infection (especially of the airways) in the last 4 weeks; 8. Paradontitis.

Design outcomes

Primary

Measure	Time frame
(Difference) in smell-prints between patients with lung cancer AND breast cancer.	—

Secondary

Measure	Time frame
1. Difference in smell-prints between patients with breast cancer and controls; 2. Difference in smell-prints between patients with lung cancer and controls; 3. Difference in smellprints between patients before and twice after resection of the lung tumour (at 1 and 6 week post-resection).	—

Contacts

Public ContactJ. Maten, van der

Dept. of pulmonary diseases MCL Leeuwarden

j.maten@znb.nl+31 (0)58 286 6190

Outcome results